Home LiteratureArticle Details
PMID: 11249901 Published · ppublish English Journal Article

Effect of concomitant or very early statin administration on in-hospital mortality and reinfarction in patients with acute myocardial infarction.

The American journal of cardiology ·Vol. 87 ·No. 6 ·2001-03-15 ·Pages 771-4, A7

Bybee KA, Wright RS, Williams BA, Murphy JG, Holmes DR, Kopecky SL

Abstract

In a retrospective analysis, 66 patients identified as having received a statin drug within 24 hours of admission for acute myocardial infarction were matched 3:1 with a control group of 198 patients not treated with a statin agent. End points of in-hospital mortality and in-hospital reinfarction were significantly lower in the statin-treated group, pointing to a benefit from very early statin treatment in acute myocardial infarction.

MeSH Terms
Aged Drug Administration Schedule Female Hospital Mortality Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage Hypolipidemic Agents/administration & dosage Male Myocardial Infarction/mortality,therapy Recurrence Retrospective Studies Survival Rate Time Factors
Chemicals
Hydroxymethylglutaryl-CoA Reductase Inhibitors Hypolipidemic Agents
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Bybee K A
Department of Internal Medicine, Mayo Physician Alliance for Clinical Trials, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Wright R S
Williams B A
Murphy J G
Holmes D R
Kopecky S L
Article Info
Journal
The American journal of cardiology
Abbr.
Am J Cardiol
ISSN
0002-9149
Published
2001-03-15
Pages
771-4, A7
Language
English
Region
United States
NLM ID
0207277
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]